Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,687 | 7,270 | 7,255 | 6,365 | 5,008 |
| Receivables | 944 | 787 | 730 | 1,084 | 536 |
| Inventories | 2,179 | 2,447 | 2,604 | 2,954 | 3,317 |
| Other current assets | 554 | 466 | 301 | 237 | 219 |
| TOTAL | $10,436 | $11,024 | $10,937 | $10,710 | $9,147 |
| Non-Current Assets | |||||
| PPE Net | 86 | 93 | 100 | 107 | 113 |
| TOTAL | $86 | $93 | $100 | $107 | $113 |
| Total Assets | $10,522 | $11,117 | $11,037 | $10,817 | $9,260 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 235 | 43 | 233 | 178 | 185 |
| Accrued Expenses | 734 | 599 | 599 | 713 | 478 |
| Other current liabilities | 386 | 2,320 | 2,119 | 1,729 | 1,565 |
| TOTAL | $1,355 | $2,962 | $2,954 | $2,627 | $2,238 |
| Non-Current Liabilities | |||||
| Long Term Debt | 930 | 1,523 | 1,394 | 1,302 | N/A |
| Other Non-Current Liabilities | -2,638 | -2,778 | -2,483 | -2,208 | -1,855 |
| TOTAL | $930 | $1,523 | $1,394 | $1,302 | $0 |
| Total Liabilities | $2,285 | $4,485 | $4,348 | $3,929 | $2,238 |
| Shareholders' Equity | |||||
| Retained earnings | -36,032 | -38,027 | -36,080 | -35,490 | -34,908 |
| TOTAL | $5,599 | $3,854 | $4,206 | $4,680 | $5,167 |
| Total Liabilities And Equity | $7,884 | $8,339 | $8,554 | $8,609 | $7,405 |